Bone Biologics Co. (NASDAQ:BBLGW – Get Free Report)’s stock price was down 6.5% during trading on Monday . The stock traded as low as $62.05 and last traded at $67.33. Approximately 2,848 shares were traded during trading, an increase of 101% from the average daily volume of 1,415 shares. The stock had previously closed at $72.00.
Bone Biologics Stock Down 6.5 %
The business has a 50 day simple moving average of $39.33 and a two-hundred day simple moving average of $48.24.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Articles
- Five stocks we like better than Bone Biologics
- What Does a Stock Split Mean?
- Sizing Up a New Opportunity for NVIDIA Investors
- Expert Stock Trading Psychology Tips
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
